A small regulatory element from chromosome 19 enhances liver-specific gene expression

Area of Science:

• Molecular Biology
• Gene Therapy
• Virology

Background:

• Adeno-associated virus (AAV) vectors are limited by the size of tissue-specific promoters.
• Small, effective regulatory elements are needed for AAV gene therapy.
• The AAVS1 integration site on human chromosome 19 contains regulatory elements.

Purpose of the Study:

• To characterize the regulatory functions of a 347 bp fragment (Chr19) from the AAVS1 site.
• To investigate the application of this fragment in adeno-associated virus (AAV) gene therapy.
• To evaluate the fragment's potential for driving transgene expression in vitro and in vivo.

Main Methods:

• Dissection of the Chr19 fragment into functional elements (promoter, insulator, enhancer) in human embryonic kidney cells.
• Construction of a mini-CMV promoter cassette with the Chr19 enhancer region.
• Transduction of cells and in vivo studies (tail vein and muscle injection) using AAV2 vectors driving reporter gene expression.

Main Results:

• The Chr19 fragment exhibits TATA-independent promoter activity and an orientation-dependent insulator function.
• A small 107 bp enhancer region was identified near the 3' end.
• In vivo, the Chr19-mini-CMV cassette enhanced liver transgene expression after tail vein injection, outperforming TTR promoter.
• Enhanced expression was not observed after muscle injection, indicating tissue specificity.

Conclusions:

• A small 347 bp DNA fragment from AAVS1 possesses promoter and enhancer activities.
• This fragment can drive efficient and enhanced liver-specific transcription in recombinant AAV vectors.
• The Chr19 fragment represents a valuable small regulatory element for AAV gene therapy applications.